ThromboVision Raises $400K

Houston, Texas-based ThromboVision, a developer of biomedical diagnostics products, has raised $400K in the first tranche of a Series A financing. The firm said that the investment will be used to fund the firm's clinical trials, to build its infrastructure, and advanced FDA approval. ThromboVision is developing a system to monitor platelet function. The firm said that its prior funding has been through grants from the National Institutes of Health (NIH) totaling nearly $4 million.